Reference 2018-219

REF:        2018-219   

Subject:    Urothelial Cell Cancer   

 

 

Request:

Please indicate the number of metastatic or locally advanced Urothelial cancer patients treated by your Trust in the 3 months, December 2017 to February 2018 inclusive.

If data is not held in a sufficient way within your Trust systems, i.e. if for example you are unable to distinguish between cancer type and/or stage, please indicate accordingly within the tables below.

  Total number treated (Metastatic/locally advanced Urothelial patients) If unable to provide number of metastatic/locally advanced Urothelial patients, please indicate the level at which data has been provided:

 

Total number of metastatic or locally advanced Urothelial cancer (UCC, transitional carcinoma, TCC) patients treated      Total Urothelial Cancer patients (any stage)  
   Other (please specify)  
   Data not held/accessible  

 

Of the metastatic or locally advanced Urothelial cancer patients treated by your Trust in the 3 months, December 2017 to February 2018 inclusive, please indicate the number treated with the following therapies.

Therapy Total number treated (Metastatic/locally advanced Urothelial patients) If unable to provide number of metastatic/locally advanced Urothelial patients, please indicate the level at which data has been provided:

 

Cisplatin  (mono or combination therapy)         Total Urothelial Cancer patients (any stage)  
      Other (please specify)  
      Data not held/accessible  
Carboplatin  (mono or combination therapy)      Total Urothelial Cancer patients (any stage)  
   Other (please specify)  
   Data not held/accessible  
Pembrolizumab (Keytruda)      Total Urothelial Cancer patients (any stage)  
   Other (please specify)  
   Data not held/accessible  
Atezolizumab (Tecentriq)      Total Urothelial Cancer patients (any stage)  
   Other (please specify)  
   Data not held/accessible  

 

If your trust does not treat these cancers and you refer your patients to another trust, please state to which trust(s) patients are referred:

 

 

Response:

Please find information attached.

2018-219 – FOI Request – Urothelial Cell Cancer [208 kb] PDF